Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]
Champions Oncology, Inc. (CSBR)
NASDAQ:AMEX Investor Relations:
championsoncology.com/investors
Company Research
Source: Yahoo! Finance
NASDAQ:CSBR ) have had an unfortunate run in the last three years. Unfortunately, they have held through a 61% decline in the share price in that time. And the ride hasn't got any smoother in recent times over the last year, with the price 30% lower in that time. Unfortunately the share price momentum is still quite negative, with prices down 16% in thirty days. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. Check out our latest analysis for Champions Oncology Given that Champions Oncology didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit. Over three years, Champions Oncology grew revenue at 4.2% per yea
Show less
Read more
Impact Snapshot
Event Time:
CSBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSBR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSBR alerts
High impacting Champions Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CSBR
News
- Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell MedicineAccesswire
- Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]Yahoo! Finance
- Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]Yahoo! Finance
CSBR
Earnings
- 12/12/23 - Beat
CSBR
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- CSBR's page on the SEC website